SEATTLE--(BUSINESS WIRE)--Tignis, a technology innovator in AI process control for semiconductor manufacturing, today announced the completion of $7.2 million in Series A Funding led by early-stage ...
Join our daily and weekly newsletters for the latest updates and exclusive content on industry-leading AI coverage. Learn More Tignis has announced a $7.2 million series A funding. The company creates ...
With PAT, pharmaceutical manufacturers achieve real-time process control, enhancing drug quality and accelerating the ...
Even after 20 years or so, process control continues to be a confusing or misunderstood technology. A short description of process control is an accurate one—It’s a means of controlling manufacturing ...
Jon Herlocker, co-founder and CEO of Tignis, sat down with Semiconductor Engineering to talk about how AI in advanced process control reduces equipment variability and corrects for process drift. What ...
Process analytical technology (PAT) describes the FDA-endorsed framework for measuring and controlling pharmaceutical manufacturing processes through real-time data collection and analysis. The FDA's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results